“082” is part of the name that he chose himself—I just shortened it a bit because I was excited to get to the content of my post about NWBO’s upcoming presentation at NYAS! I love that both dendritic cell technology and checkpoint blockade technology will be featured at Frontiers in Cancer Immunotherapy 2025!
Market Data 
Markets 
